Clinical Policy: Abaloparatide (Tymlos)
Customize your policy alerts
Sign up for Arizona Complete Health Policy AZ.CP.PHAR.345 alerts
Get alerted when Policy AZ.CP.PHAR.345 changes without checking for updates manually.
Monitor payer policy activity
Arizona Medicaid coverage and prior authorization requirements for abaloparatide (Tymlos) for osteoporosis, applying to Arizona Complete Health-Complete Care Plan and Care1st members and providers.
The 2022 annual review updated the definition of very high fracture risk.
The policy added language specifying that its criteria also apply to Care1st.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.